Second-line hormonotherapy for breast cancer: Uselessness of first-line continuation

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 16, Issue 6, 1993, Pages 522-525

  Pronzato, P ^a   Rubagotti, A ^a   Amoroso, D ^a   Bertelli, G ^a   Queirolo, P ^a   Sertoli, M R ^a   Rosso, M ^a   Gallotti, P ^a   Monzeglio, C ^a   Rosso, R ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; HYDROCORTISONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DROWSINESS; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; RASH; VAGINA DISCHARGE; VERTIGO;

EID: 0027139849     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199312000-00013     Document Type: Article

References (0)